News

Octapharma Chairman receives prestigious award in Vienna

10.11.2011

Wolfgang Marguerre has been honored with the Grand Decoration of Honor in Gold (Grosses Goldenes Ehrenzeichen) for Services to the Republic of Austria.

 

Mr Wolfgang Marguerre was selected for this illustrious award by Federal President of Austria Dr Heinz Fischer. This decoration is granted to individuals who have brought outstanding public benefit to the Republic of Austria.

 

Wolfgang Marguerre joins a prestigious group of individuals similarly honored, from fellow business figures, to political leaders and royalty. Fellow Grand Decoration of Honor winners include: former chairman of the Toyota Motor Corporation, Shoichiro Toyoda; former Secretary-General of the United Nations Kofi Annan; the eminent social and political philosopher Karl Popper, who like Mr Marguerre received the Grand Decoration for Services to the Republic of Austria in Gold; celebrated psychoanalyst and daughter of Sigmund, Anna Freud, as well as countless royalty and heads of state.

 

The award was presented by Austrian Minister for Economic Affairs, Family and Youth, Dr. Reinhold Mitterlehner in a ceremony held at the Marble Hall of the ministry. Around 200 people gathered in the great hall to witness the historic ceremony.  The Austrian honors system has celebrated and honored distinguished individuals since 1952. Playing at the ceremony was Vienna’s Kamilarov string Quartet “Das Kamilarov Quartett“.

 

It is fitting that Mr Marguerre is being honored by the republic of Austria in Vienna, the home of the first Octapharma-owned production site.  On receiving this distinguished award Mr Marguerre said:

 

“I accept this award on behalf of all my staff in Vienna. Vienna was the first Octapharma site. When this plant first opened in 1990 we employed 60 people, 20 years later we employ 670. Vienna is a very important city for Octapharma. In fact, two out of my three children are moving to Vienna this year.”

 

After the ceremony Mr Marguerre and his family travelled to the Vienna plant to share in celebrations with his employees at a special reception.

 

Vienna Plant History
Octapharma’s Vienna plant is one of the most modern fractionation plants in the world. Located on the southern outskirts of Vienna it was the first plant to manufacture a solvent detergent (SD) treated Factor VIII preparation as well as the first virus-inactivated plasma for infusion.

 

About the Octapharma Group
Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 28 years. Octapharma’s core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma’s IGIV product,octagam® (immune globulin intravenous [human] 5%), is used to treat primary immune deficiencies, and Octapharma’s albumin (human)® is indicated for the restoration and maintenance of circulating blood volume. Octapharma’s wilate® (Von Willebrand Factor/Coagulation Factor VIII Complex [human]) received orphan drug exclusivity from the U.S, Food and Drug Administration (FDA) for the treatment of certain types of Von Willebrand Disease (VWD). Octapharma employs over 4,000 people and has biopharmaceutical experience in 80 countries worldwide, including the United States, where Octapharma AG is located in Hoboken, N.J.  Octapharma operates two state-of-the-art production sites licensed by the FDA, providing a high level of production flexibility. For more information, please visit www.octapharma.com or www.wilateusa.com